Cramer Rosenthal Mcglynn LLC grew its stake in Metlife Inc (NYSE:MET) by 1.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 317,427 shares of the financial services provider’s stock after acquiring an additional 3,297 shares during the period. Cramer Rosenthal Mcglynn LLC’s holdings in Metlife were worth $16,049,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors also recently made changes to their positions in the business. First Dallas Securities Inc. acquired a new stake in shares of Metlife during the 4th quarter worth approximately $111,000. Ffcm LLC grew its position in shares of Metlife by 2,020.8% during the 3rd quarter. Ffcm LLC now owns 2,248 shares of the financial services provider’s stock worth $119,000 after buying an additional 2,142 shares during the period. Sandy Spring Bank grew its position in shares of Metlife by 495.2% during the 4th quarter. Sandy Spring Bank now owns 2,375 shares of the financial services provider’s stock worth $120,000 after buying an additional 1,976 shares during the period. Valeo Financial Advisors LLC acquired a new stake in shares of Metlife during the 3rd quarter worth approximately $151,000. Finally, Premia Global Advisors LLC acquired a new stake in shares of Metlife during the 4th quarter worth approximately $170,000. 77.67% of the stock is owned by institutional investors.
Several equities research analysts have recently commented on the stock. Morgan Stanley lowered their price target on shares of Metlife from $59.00 to $58.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 14th. Zacks Investment Research upgraded shares of Metlife from a “hold” rating to a “buy” rating and set a $58.00 price target for the company in a research report on Thursday, January 18th. Goldman Sachs Group reiterated a “buy” rating on shares of Metlife in a research report on Wednesday, January 31st. ValuEngine upgraded shares of Metlife from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, March 7th. Finally, Wells Fargo & Co set a $60.00 price target on shares of Metlife and gave the stock a “buy” rating in a research report on Tuesday, February 13th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $57.90.
Metlife (NYSE:MET) last issued its quarterly earnings data on Tuesday, February 13th. The financial services provider reported $0.64 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.05 by ($0.41). The firm had revenue of $15.79 billion for the quarter, compared to analyst estimates of $15.89 billion. Metlife had a net margin of 5.69% and a return on equity of 8.59%. During the same quarter in the prior year, the firm posted $1.28 EPS. equities analysts forecast that Metlife Inc will post 4.93 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 13th. Investors of record on Monday, February 5th were issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 3.40%. The ex-dividend date was Friday, February 2nd. Metlife’s dividend payout ratio is currently 46.92%.
ILLEGAL ACTIVITY WARNING: “Metlife Inc (MET) Shares Bought by Cramer Rosenthal Mcglynn LLC” was first posted by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this piece of content can be read at https://www.americanbankingnews.com/2018/03/14/metlife-inc-met-shares-bought-by-cramer-rosenthal-mcglynn-llc.html.
MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.